The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure.
Background: Despite its high prevalence, optimal therapy for diastolic heart failure (DHF) has not been determined. Alagebrium chloride (ALT-711) is a novel compound that breaks glucose crosslinks and may improve ventricular and arterial compliance.Methods and Results: A total of 23 patients, mean a...
| Published in: | Journal of Cardiac Failure Vol. 11; no. 3; pp. 191 - 196 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | diagnostic images pictorial research tables/charts Journal Article |
| Published: |
W B Saunders
2005 Apr
|
| Online Access: | View this record in EBSCOhost |